Cited In for PMID: 17194261

Year	Number of Results
2006	1
2007	1
2008	3
2009	1
2010	4
2011	4
2012	2
2013	1
2014	10
2015	5
2016	3
2017	8
2018	3
2019	6
2020	4
2021	4
2022	2
2023	3
2024	2

1

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH. Ruhé HG, et al. J Clin Psychiatry. 2006 Dec;67(12):1836-55. doi: 10.4088/jcp.v67n1203. J Clin Psychiatry. 2006. PMID: 17194261 Review.

2

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.

Ghanbarian S, Wong GWK, Bunka M, Edwards L, Cressman S, Conte T, Peterson S, Vijh R, Price M, Schuetz C, Erickson D, Riches L, Landry G, McGrail K, Austin J, Bryan S. Ghanbarian S, et al. Pharmacoecon Open. 2024 Mar 26. doi: 10.1007/s41669-024-00481-y. Online ahead of print. Pharmacoecon Open. 2024. PMID: 38528312 Free article. Review.

3

Treatment-resistant depression: where to find hope?

Souery D. Souery D. World Psychiatry. 2023 Oct;22(3):422-423. doi: 10.1002/wps.21141. World Psychiatry. 2023. PMID: 37713550 Free PMC article. No abstract available.

4

A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult.

Blaszczyk AT, Mathys M, Le J. Blaszczyk AT, et al. Drugs Aging. 2023 Sep;40(9):785-813. doi: 10.1007/s40266-023-01051-3. Epub 2023 Aug 18. Drugs Aging. 2023. PMID: 37596380 Review.

5

The HPA Axis as Target for Depression.

Menke A. Menke A. Curr Neuropharmacol. 2024;22(5):904-915. doi: 10.2174/1570159X21666230811141557. Curr Neuropharmacol. 2024. PMID: 37581323

6

Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression.

Chang CY, Park H, Hincapie-Castillo JM, Heldermon CD, Diaby V, Yang S, Wilson DL, Lo-Ciganic WH. Chang CY, et al. J Manag Care Spec Pharm. 2023 Apr;29(4):431-445. doi: 10.18553/jmcp.2023.29.4.431. J Manag Care Spec Pharm. 2023. PMID: 36989452 Free PMC article.

7

Application of the Delphi Method in the Study of Depressive Disorder.

Wu H, Xu L, Zheng Y, Shi L, Zhai L, Xu F. Wu H, et al. Front Psychiatry. 2022 Jul 7;13:925610. doi: 10.3389/fpsyt.2022.925610. eCollection 2022. Front Psychiatry. 2022. PMID: 35873226 Free PMC article. Review.

8

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study.

Del Casale A, Pomes LM, Bonanni L, Fiaschè F, Zocchi C, Padovano A, De Luca O, Angeletti G, Brugnoli R, Girardi P, Preissner R, Borro M, Gentile G, Pompili M, Simmaco M. Del Casale A, et al. J Pers Med. 2022 Feb 19;12(2):316. doi: 10.3390/jpm12020316. J Pers Med. 2022. PMID: 35207804 Free PMC article.

9

Are Noradrenergic Transmission Reducing Drugs Antidepressants?

Fitzgerald PJ. Fitzgerald PJ. Front Behav Neurosci. 2021 Sep 30;15:673634. doi: 10.3389/fnbeh.2021.673634. eCollection 2021. Front Behav Neurosci. 2021. PMID: 34658805 Free PMC article.

10

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

Wolff J, Reißner P, Hefner G, Normann C, Kaier K, Binder H, Hiemke C, Toto S, Domschke K, Marschollek M, Klimke A. Wolff J, et al. PLoS One. 2021 Jul 22;16(7):e0255192. doi: 10.1371/journal.pone.0255192. eCollection 2021. PLoS One. 2021. PMID: 34293068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year